SillaJen, Inc. (215600.KQ)
KRW 2565.0
(0.79%)
KRW 2565.0
(0.79%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 76.71 Billion KRW | -25.84% |
| 2022 | 103.44 Billion KRW | -23.28% |
| 2021 | 134.82 Billion KRW | 184.31% |
| 2020 | 47.42 Billion KRW | -32.0% |
| 2019 | 69.74 Billion KRW | -63.9% |
| 2018 | 193.19 Billion KRW | -17.77% |
| 2017 | 234.95 Billion KRW | -17.31% |
| 2016 | 284.12 Billion KRW | 85.67% |
| 2015 | 153.02 Billion KRW | -10.87% |
| 2014 | 171.68 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 166.67 Billion KRW | 132.5% |
| 2024 Q1 | 71.68 Billion KRW | -6.56% |
| 2023 FY | 76.71 Billion KRW | -25.84% |
| 2023 Q3 | 84.35 Billion KRW | -10.03% |
| 2023 Q1 | 98.94 Billion KRW | -4.35% |
| 2023 Q4 | 76.71 Billion KRW | -9.06% |
| 2023 Q2 | 93.76 Billion KRW | -5.24% |
| 2022 Q2 | 115.94 Billion KRW | -8.58% |
| 2022 Q4 | 103.44 Billion KRW | -6.17% |
| 2022 FY | 103.44 Billion KRW | -23.28% |
| 2022 Q3 | 110.25 Billion KRW | -4.91% |
| 2022 Q1 | 126.81 Billion KRW | -5.94% |
| 2021 FY | 134.82 Billion KRW | 184.31% |
| 2021 Q2 | 47.57 Billion KRW | 2.67% |
| 2021 Q3 | 141.3 Billion KRW | 197.04% |
| 2021 Q4 | 134.82 Billion KRW | -4.59% |
| 2021 Q1 | 46.33 Billion KRW | -2.29% |
| 2020 Q4 | 47.42 Billion KRW | -22.77% |
| 2020 FY | 47.42 Billion KRW | -32.0% |
| 2020 Q3 | 61.4 Billion KRW | -12.51% |
| 2020 Q2 | 70.18 Billion KRW | 11.98% |
| 2020 Q1 | 62.67 Billion KRW | -10.14% |
| 2019 FY | 69.74 Billion KRW | -63.9% |
| 2019 Q4 | 69.74 Billion KRW | -64.1% |
| 2019 Q3 | 194.28 Billion KRW | -4.84% |
| 2019 Q2 | 204.17 Billion KRW | -29.05% |
| 2019 Q1 | 287.76 Billion KRW | 48.95% |
| 2018 Q4 | 193.19 Billion KRW | -5.65% |
| 2018 Q2 | 215.79 Billion KRW | -2.42% |
| 2018 Q3 | 204.77 Billion KRW | -5.11% |
| 2018 Q1 | 221.14 Billion KRW | -5.88% |
| 2018 FY | 193.19 Billion KRW | -17.77% |
| 2017 Q2 | 260.08 Billion KRW | -3.47% |
| 2017 Q1 | 269.44 Billion KRW | -5.17% |
| 2017 Q4 | 234.95 Billion KRW | -7.57% |
| 2017 Q3 | 254.18 Billion KRW | -2.27% |
| 2017 FY | 234.95 Billion KRW | -17.31% |
| 2016 Q2 | 153.99 Billion KRW | 1.69% |
| 2016 Q4 | 284.12 Billion KRW | 104.22% |
| 2016 Q3 | 139.13 Billion KRW | -9.65% |
| 2016 Q1 | 151.43 Billion KRW | -1.04% |
| 2016 FY | 284.12 Billion KRW | 85.67% |
| 2015 Q1 | 132.02 Billion KRW | -23.1% |
| 2015 Q3 | 128.16 Billion KRW | -0.08% |
| 2015 Q4 | 153.02 Billion KRW | 19.4% |
| 2015 Q2 | 128.26 Billion KRW | -2.85% |
| 2015 FY | 153.02 Billion KRW | -10.87% |
| 2014 FY | 171.68 Billion KRW | 0.0% |
| 2014 Q4 | 171.68 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| HLB Co., Ltd. | 751.72 Billion KRW | 89.795% |
| iNtRON Biotechnology, Inc. | 98.61 Billion KRW | 22.207% |
| BINEX Co., Ltd. | 257.01 Billion KRW | 70.151% |
| Bioneer Corporation | 315.48 Billion KRW | 75.684% |
| Anterogen.Co.,Ltd. | 149.43 Billion KRW | 48.662% |
| MEDIPOST Co., Ltd. | 449.39 Billion KRW | 82.929% |
| CrystalGenomics, Inc. | 243.11 Billion USD | 68.445% |
| Helixmith Co., Ltd | 227.27 Billion KRW | 66.246% |
| Chabiotech Co.,Ltd. | 1725.57 Billion KRW | 95.554% |
| Medy-Tox Inc. | 611.62 Billion KRW | 87.457% |
| Peptron, Inc. | 52.49 Billion KRW | -46.135% |
| Amicogen, Inc. | 467.09 Billion KRW | 83.576% |
| Genexine, Inc. | 376.58 Billion KRW | 79.629% |
| HLB Therapeutics Co.,Ltd. | 200.79 Billion KRW | 61.794% |
| LegoChem Biosciences, Inc. | 189.5 Billion KRW | 59.518% |
| ALTEOGEN Inc. | 256.09 Billion KRW | 70.045% |
| PharmaResearch Co., Ltd. | 535.28 Billion KRW | 85.668% |
| JETEMA, Co., Ltd. | 252.14 Billion KRW | 69.575% |
| OliX Pharmaceuticals,Inc | 102.82 Billion KRW | 25.393% |
| Genomictree Inc. | 132.84 Billion KRW | 42.252% |
| MedPacto, Inc. | 80.47 Billion KRW | 4.672% |
| D&D Pharmatech | 79.2 Billion KRW | 3.142% |
| EASY BIO,Inc. | 172.04 Billion KRW | 55.409% |
| GI Innovation, Inc. | 81.34 Billion KRW | 5.686% |